J INTERN MED:急性肝卟啉症患者发生原发性肝癌的风险

2022-02-09 MedSci原创 MedSci原创

该研究证实了较高的原发性肝癌风险,并确定了与临床和生化AIP活动密切相关。对50岁以上有活动性AIP病史的患者应进行定期原发性肝癌监测。

急性肝卟啉症与原发性肝癌的风险相关,但风险估计尚未明确,预测原发性肝癌风险的急性肝卟啉症特征也未完全明确。

近日,内科学领域权威杂志Journal of Internal Medicine上发表一篇研究文章,在这项基于登记的匹配队列研究中,研究人员评估了与生化和临床卟啉症严重程度、基因型、年龄和性别相关的原发性肝癌风险。

研究人员纳入了1987-2015年期间瑞典卟啉病登记中心患有急性间歇性卟啉症(AIP)、杂色卟啉症(VP)或遗传性粪卟啉症(HCP)的所有患者。这个急性肝卟啉症队列与来自一般人群的年龄、性别和县匹配的参考个体进行了比较。研究人员使用基于国家登记的急性肝卟啉症入院来指示临床严重程度。对于最常见的急性肝卟啉症类型AIP,患者按基因型和尿胆色素原(U-PBG)进行了分层。原发性肝癌数据是从国家卫生登记处进行收集的。

研究人员确定了1244名急性肝卟啉症患者(1063名[85%]AIP患者)。在19.5年的中位随访期间,研究人员确定了108例原发性肝癌病例,包括83名急性肝卟啉症患者(6.7%)和25/12333名(0.2%)对照个体。急性肝卟啉症-原发性肝癌的调整后风险比为38.0(95%置信区间为24.3-59.3)。先前升高的U-PBG和卟啉症住院相关,但与AIP基因型或性别无关,与原发性肝癌风险增加有关。年龄>50岁且既往伴有U-PBG升高的患者(n=157)原发性肝癌年度发病率为1.8%

由此可见,该研究证实了较高的原发性肝癌风险,并确定了与临床和生化AIP活动密切相关。对50岁以上有活动性AIP病史的患者应进行定期原发性肝癌监测。

原始出处:

Mattias Lissing,et al.Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1,244 individuals
.Journal of Internal Medicine.2022.https://onlinelibrary.wiley.com/doi/10.1111/joim.13463.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847027, encodeId=4f08184e02774, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Tue Dec 27 01:36:22 CST 2022, time=2022-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257505, encodeId=91a5125e50586, content=<a href='/topic/show?id=df433e09082' target=_blank style='color:#2F92EE;'>#原发性肝癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37090, encryptionId=df433e09082, topicName=原发性肝癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416173, encodeId=8bb214161e321, content=<a href='/topic/show?id=9841523e93a' target=_blank style='color:#2F92EE;'>#急性肝卟啉症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52379, encryptionId=9841523e93a, topicName=急性肝卟啉症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85413143250, createdName=changjitao2010, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611436, encodeId=7ce3161143652, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1847027, encodeId=4f08184e02774, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Tue Dec 27 01:36:22 CST 2022, time=2022-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257505, encodeId=91a5125e50586, content=<a href='/topic/show?id=df433e09082' target=_blank style='color:#2F92EE;'>#原发性肝癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37090, encryptionId=df433e09082, topicName=原发性肝癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416173, encodeId=8bb214161e321, content=<a href='/topic/show?id=9841523e93a' target=_blank style='color:#2F92EE;'>#急性肝卟啉症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52379, encryptionId=9841523e93a, topicName=急性肝卟啉症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85413143250, createdName=changjitao2010, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611436, encodeId=7ce3161143652, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1847027, encodeId=4f08184e02774, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Tue Dec 27 01:36:22 CST 2022, time=2022-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257505, encodeId=91a5125e50586, content=<a href='/topic/show?id=df433e09082' target=_blank style='color:#2F92EE;'>#原发性肝癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37090, encryptionId=df433e09082, topicName=原发性肝癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416173, encodeId=8bb214161e321, content=<a href='/topic/show?id=9841523e93a' target=_blank style='color:#2F92EE;'>#急性肝卟啉症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52379, encryptionId=9841523e93a, topicName=急性肝卟啉症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85413143250, createdName=changjitao2010, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611436, encodeId=7ce3161143652, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1847027, encodeId=4f08184e02774, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Tue Dec 27 01:36:22 CST 2022, time=2022-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257505, encodeId=91a5125e50586, content=<a href='/topic/show?id=df433e09082' target=_blank style='color:#2F92EE;'>#原发性肝癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37090, encryptionId=df433e09082, topicName=原发性肝癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416173, encodeId=8bb214161e321, content=<a href='/topic/show?id=9841523e93a' target=_blank style='color:#2F92EE;'>#急性肝卟啉症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52379, encryptionId=9841523e93a, topicName=急性肝卟啉症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85413143250, createdName=changjitao2010, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611436, encodeId=7ce3161143652, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 09 07:36:22 CST 2022, time=2022-02-09, status=1, ipAttribution=)]
    2022-02-09 zhouqu_8

相关资讯

JAMA:HFE p.C282Y纯合子男性人群的肝癌风险显著增加

男性HFE p.C282Y纯合子携带者的发性肝脏恶性肿瘤和死亡风险显著增加,相比于男性,女性纯合子携带者的风险较低

J Immunother Cancer:Camrelizumab联合阿帕替尼治疗晚期肝癌的效果

人源PD-1单克隆抗体Camrelizumab联合阿帕替尼治疗晚期肝癌的效果

Dig Dis Sci:中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关

肝细胞癌(HCC)是一种致命的癌症,预后不良,是美国癌症相关死亡率上升最快的原因之一。肝癌的预后取决于多种因素,包括肿瘤负担,肝功能障碍程度等。

杨田教授:2020年版《CSCO原发性肝癌诊疗指南》更新要点解读,聚焦免疫靶向联合治疗

近两年,肝癌临床研究成果凸显,尤以内科治疗领域发展更为迅速。2020年版《CSCO原发性肝癌诊疗指南》也与时俱进,吸纳了最新的循证医学进展,更新创新治疗理念,以求更好地指导广大医生的临床实践。

卫健委发布新版肝癌诊疗指南,“七大”更新内容速度围观!

本文特此梳理了新版指南中的“七大”主要更新内容,以飨读者。

祸不单行!肝癌患者全血细胞减少,竟合并了最凶险的……

原发性肝癌是指发生于肝细胞或肝内胆管细胞的癌肿,其中肝细胞癌(HCC)占原发性肝癌中的绝大多数,胆管细胞癌不足5%。本病恶性程度高,浸润和转移性强,远期疗效取决于能否早期诊断及早期治疗。